Current issue
Archive
Online first
About the Journal
Editorial Office
Editorial Board
Publisher
Editorial Policies
Ethical standards and procedures
Abstracting and indexing
Reviewers
Honorary Reviewers
Subscription
Contact
Most read articles
Instructions for authors
Article processing charge (APC)
Books and Events
Books
Events
REVIEW PAPER
Non-steroidal anti-inflammatory drug-induced intestinal damage
Online publication date: 2012-06-27
Reumatologia 2012;50(3):219-226
KEYWORDS
ABSTRACT
Well-known adverse effects of non-steroidal anti-inflammatory drugs on the gastrointestinal mucosa and their common use are associated with an increased risk of toxicity. The influence of mentioned drugs on the mucosal membrane of the stomach and duodenum is relatively widely known. The paper reviews the intestinal side effects of non-steroidal anti-inflammatory drugs.
REFERENCES (62)
1.
Derry S, Loke YK. Risk of gastriointestinal haemoorrhage with long term use of aspiryn: meta-analysis. Br Med J 2000; 321: 1183-1187.
2.
Longstreth GF. Epidemiology and outcome of patients hospitalized with acute lower gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol 1997; 92: 419-424.
3.
Peura DA, Lanza FL, Goustout CJ. The American College of Gastroenterology Bleeding Registry: preliminary findings. Am J Gastroenterol 1997; 92: 924-928.
4.
Billingham RP. The conundrum of lower gastrointestinal bleeding. Surg Clin North Am 1997; 77: 241-252.
5.
Zuckerman GR, Prakash C. Acute lower intestinal bleeding. Part II. Etiology, therapy, and outcomes. Gastrointest Endosc 1999; 49: 228.
6.
Maiden L, Thjodleifsson B, Theodors A, et al. A Quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology 2005; 128: 1172-1178.
7.
Goldstein JL, Eisen GM, Lewis B, et al. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol 2005; 3: 133-141.
8.
Hayashi Y, Yamamoto H, Kita H, et al. Non-steroidal anti-inflammatory drug-induced small bowel injuries identified by double-balloon endoscopy. World J Gastroenterol 2005; 11: 4861-4864.
9.
Shorr R, Ray W, Daugherty J, Griffin M. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease. Arch Intern Med 1993; 153: 1665-1670.
10.
de Abajo FJ, Rodriguez LA, van Walraven C, et al. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ 2001; 323: 655-658.
11.
Helin-Salmivaara A, Huupponen R, Virtanen A, et al. Frequent prescribing of drugs with potential gastrointestinal toxicity among continuous users of non-steroidal anti-inflammatory drugs. Eur J Clin Pharmacol 2005; 61: 425-431.
12.
Somasundaram S, Sigthorsson G, Simpson RJ, et al. Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID enteropathy in the rat. Aliment Pharmacol Ther 2000; 14: 639-650.
13.
Smecuol E, Bai JC, Sugai E, et al. Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs. Gut 2001; 49: 650-655.
14.
Choi VM, Coates JE, Chooi J, et al. Small bowel permeability – a variable effect of NSAIDS. Clin Invest Med 1995; 18: 357-361.
15.
Bjarnason I, Smethurst P, Macpherson A, et al. Glucose and citrate reduce the permeability changes caused by indomethacin in humans. Gastroenterology 1992; 102: 1546-1550.
16.
Tibble JA, Sigthorsson G, Foster R, Bjarnason I. Comparison of the intestinal toxicity of celecoxib, a selective COX-2 inhibitor, and indomethacin in the experimental rat. Scand J Gastroenterol 2000; 35: 802-807.
17.
Bjarnason I, Williams P, So A, et al. Intestinal permeability and inflammation in rheumatoid arthritis; effects of non-steroidal anti-inflammatory drugs. Lancet 1984; 2: 1171-1174.
19.
us systemic effects of increasing small intestinal permeability in man. Gut 1991; 32: 275-277.
20.
Stadnyk AW, Dollard C, Issekutz TB, Issekutz AC. Neutrophil migration into indomethacin induced rat small intestinal injury is CD11a/CD18 and CD11b/CD18 co-dependent. Gut 2002; 50: 629-635.
21.
Shah AA, Thjodleifsson B, Murray FE, et al. Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen. Gut 2001; 48: 339-346.
22.
Davies NM, Jamali F. Pharmacological protection of NSAID-induced intestinal permeability in the rat: effect of tempo and metronidazole as potential free radical scavengers. Hum Exp Toxicol 1997; 16: 345-349.
23.
Robert A, Asano T. Resistance of germ-free rats to indomethacin-induced intestinal lesions. Prostaglandins 1977; 14: 333-341.
24.
Fujiwara Y, Oshitani N, Asahara T, et al. Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut 2008; 57: 181-187.
25.
Kawai T, Takeuchi O, Fujita T, et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 2001; 167: 5887-5894.
26.
Zughaier SM, Zimmer SM, Datta A, et al. Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins. Infect Immun 2005; 73: 2940-2950.
27.
Nomura F, Akashi S, Sakao Y, et al. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol 2000; 164: 3476-3479.
28.
Reuter BK, Davies NM, Wallace JL. Nonsteroidal anti-infl ammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic recirculation. Gastroenterology 1997; 112: 109-117.
29.
Lichtenberger LM, Phan T, Okabe S. Aspirin’s ability to induce intestinal injury in rats is dependent on bile and can be reversed if pre-associated with phosphatidylcholine. J Physiol Pharmacol 2011; 62: 491-496.
30.
Bjarnason I, Zanelli G, Prouse P, et al. Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs. Lancet 1987; 2: 711-714.
31.
Hooker GD, Gregor JC, Ponich TP, McLarty TD. Diaphragm-like strictures of the right colon induced by indomethacin suppositories: evidence of a systemic effect. Gastrointest Endosc 1996; 44: 199-202.
32.
Halter F, Weber B, Huber T, et al. Diaphragm disease of the ascending colon. Association with sustained-release diclofenac. J Clin Gastroenterol 1993; 16: 74-80.
33.
Fernando SS, McGovern VJ. Neuromuscular and vascular hamartoma of small bowel. Gut 1982; 23: 1008-1012.
34.
Cortina G, Wren S, Armstrong B, et al. Clinical and pathologic overlap in nonsteroidal anti-inflammatory drug-related small bowel diaphragm disease and the neuromuscular and vascular hamartoma of the small bowel. Am J Surg Pathol 1999; 23: 1414-1417.
35.
Nagaraj HS, Sandhu AS, Cook LN, et al. Gastrointestinal perforation following indomethacin in very low birth weight infants. J Paediat Surg 1981; 16: 1003-1007.
36.
Evans JM, McMahon AD, Murray FE, et al. Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut 1997; 40: 619-622. .
37.
Rex DK, Cutler CS, Lemmel GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997; 112: 24-28.
39.
Siddiqui AR, Schauwecker DS, Wellman HN, Mock BH. Comparison of technetium-99m sulfur solid and in vitro labeled technetium-99m RBCs in the detection of gastrointestinal bleeding. Clin Nucl Med 1985; 8: 546-549.
40.
Hunter JM, Talmor M, Jennis R, et al. Accurate localization and surgical management of active lower gastrointestinal hemorrhage witch technetium-labeled erythrocyte scintigraphy. Ann Surg 1996; 224: 29-36.
42.
Gutierrez C, Mariano M, Vander Laan T, et al. The use of technetium-labeled erythrocyte scintigraphy in the evaluation and treatment of lower gastrointestinal hemorrhage. Am Surg 1998; 64: 989-992.
43.
Lau WY, Fan ST, Wong SH, et al. Preoperative and intraoperative localization of gastrointestinal bleeding of obscure origin. Gut 1987; 28: 869-877.
44.
Rex DK, Lappas JC, Maglinte DT, et al. Enteroclysis in the evaluation of suspected small intestinal bleeding. Gastroenterology 1989; 97: 58-60.
45.
Mylonaki M, Fritscher-Ravens A, Swain P. Wireless capsule endoscopy: a comparison with push enteroscopy in patients with gastroscopy and colonoscopy negative gastrointestinal bleeding. Gut 2003; 52: 1122-1126.
46.
Pennazio M, Santucci R, Rondonotti E, et al. Outcome of patients with obscure gastrointestinal bleeding after capsule endoscopy: report of 100 consecutive cases. Gastroenterology 2004; 126: 643-653.
47.
Suzuki T, Matsushima M, Okita I, et al. Clinical utility of double-balloon enteroscopy for small intestinal bleeding. Dig Dis Sci 2007; 52: 1914-1918.
48.
Yamamoto H, Sekine Y, Sato Y, et al. Total enteroscopy with a nonsurgical steerable double-balloon method. Gastrointest Endosc 2001; 53: 216-220. .
49.
Yamamoto H, Kita H, Sunada K, et al. Clinical outcomes of double-balloon endoscopy for the diagnosis and treatment of small-intestinal diseases. Clin Gastroenterol Hepatol 2004; 2: 1010-1016.
50.
Cave DR. Obscure gastrointestinal bleeding: the role of the tagged red blood cell scan, enteroscopy, and capsule endoscopy. Clin Gastroenterol Hepatol 2005; 3: 959-963.
51.
Iwamoto J, Saito Y, Honda A, et al. Clinical feature of a small intestinal mucosal injury in chronic NSAID users in Japan. J Gastrointestin Liver Dis 2012; 21: 108-111.
52.
Hsu CM, Chiu CT, Su MY, et al. The outcome assessment of double-balloon enteroscopy for diagnosing and managing patients with obscure gastrointestinal bleeding. Dig Dis Sci 2007; 62: 162-166.
53.
Heine GD, Hadithi M, Groenen MJ, et al. Double-balloon enteroscopy: indications, diagnostic yield, and complications in a series of 275 patients with suspected small-bowel disease. Endoscopy 2006; 38: 42-48.
54.
Satoh H, Takeuchi K. Management of NSAID/aspirin-induced small intestinal damage by GI-sparing NSAIDs, antiulcer drugs and food constituents. Curr Med Chem 2012; 19: 82-89.
55.
Fiorucci S, Santucci L, Gresele P, et al. Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study. Gastroenterology 2003; 124: 600-607.
56.
Hawkey CJ, Jones JI, Atherton CT, et al. Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans. Gut 2003; 52: 1537-1542.
57.
Saud B, Nandi J, Ong G, et al. Inhibition of TNF-αlpha improves indomethacin-induced enteropathy in rats by modulating iNOS expression. Dig Dis Sci 2005; 50: 1677-1683.
58.
Arndt H, Paltisch KD, Grisham MB, Granger DN. Metronidazole inhibits leukocyte endothelial cell adhesion in rat mesenteric venules. Gastroenterology 1994; 106: 1271-1276.
59.
Scarpignato C, Pelosini I. Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential. Chemotherapy 2005; 51 (suppl 1): 36-66.
60.
Hayllar J, Smith T, Macpherson A, et al. Nonsteroidal antiinflammatory drug-induced small intestinal inflammation and blood loss. Effects of sulfasalazine and other disease-modifying antirheumatic drugs. Arthritis Rheum 1994; 37: 1146-1150.
61.
Chan FK, Lanas A, Scheiman J, et al. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomized trial. Lancet 2010; 376: 173-179.
62.
Park SC, Chun HJ, Kang CD, Sul D. Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury. World J Gastroenterol 2011; 17: 4647-4653.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
RELATED ARTICLE
| eISSN: | 2084-9834 |
| ISSN: | 0034-6233 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
